Epigenetic deregulation of IGF2 and cervical cancer precursors in HIV+ and HIV- patients by Hoyo, Cathrine et al.
MEETING ABSTRACTS Open Access
Epigenetic deregulation of IGF2 and cervical
cancer precursors in HIV+ and HIV- patients
Cathrine Hoyo
1*, Francine Overcash
1, Zhiqing Huang
2, Olola Oneko
3, Brandi Vaquez
4, Joseph Obure
3, Pendo Mlay
3,
John Bartlett
5, Brenda Hernandez
6, Susan K Murphy
2
From 12
th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies
(ICMAOI)
Bethesda, MD, USA. 26-27 April, 2010
Introduction
Early detection and aggressive treatment programs to
prevent cervical carcinoma in situ (CIS) and invasive
uterine cervical cancer (ICC) have been available for
more than 30 years with more than 80% population cov-
erage. Despite this, 11,000 cases of ICC and 40,000 cases
of CIS continue to be diagnosed in the United States
annually. Women of African descent are at >2-fold
higher risk of invasive cervical cancer death compared
to other ethnic groups.
Objective
The overarching goal is to develop epigenetic biomar-
kers that can be used for early identification of aggres-
sive cases likely to result in invasive cervical cancer and
death.
Methods
We conducted a hospital-based, case-control study com-
prising 26 women with ICC, 18 with CIN2/3/HSIL and
41 with normal cytology, at Kilimanjaro Christian Medi-
cal Center in Moshi, Tanzania. We analyzed methylation
of three regions in the IGF2/H19 imprinted domain
known to regulate the expression of imprinted IGF2.
Aberrant methylation is associated with IGF2 deregula-
tion, including changes in expression, loss of imprinting,
and neoplasia.
Results
At the IGF2/H19 imprint center upstream of H19,
methylation profiles for all women with no evidence of
cervical abnormality or those with CIN2-CIN3 were
within normal ranges (40%-60%), while 23% with inva-
sive cancer had hypermethylation. In contrast, 25% of
the CIN2/3 cases were abnormally hypomethylated at
the IGF2 DMR in IGF2 intron 2, and the methylation
profile worsened in the invasive cervical cancer cases
with 64% having an abnormal methylation profile.
A similar trend was found for the regulatory region in
IGF2 intron 6. Stratifying these analyses by HIV status
in ICC revealed that aberrant intragenic IGF2 hypo-
methylation was observed only among women without
HIV. These associations persisted after adjusting for
HPV genotype.
Conclusion
Our findings suggest that regulation of IGF2 is sub-
stantially altered in CIN2 or worse via epigenetic
alterations. DNA methylation profiles of these regions
may be markers of risk of progression especially in
HIV- women. The findings support our hypothesis that
epigenetic deregulation of this imprinted gene could be
useful in discriminating women with dysplasia likely to
progress.
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